Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 24)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
6-Feb-10Standard & Poor's Quantitative ReportN/AChelsea Therapeutics Intl6$25  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: CHELSEA THERAPEU -- CHTP1$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ALSE , CVM , CHTP , CYCC , CUR -- DRUGS3$4  View Abstract
25-Jan-10Argus Research CorporationDavid ColemanVickers Weekly Insider, 01/25/1029$50  View Abstract
21-Jan-10Zacks Investment Research Inc.N/ACHELSEA THERAP (CHTP) Zacks Company Snapshot1$10  View Abstract
19-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary14$50  View Abstract
19-Jan-10Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew Vaino PhDRaising Price Target After Chatting With Chelsea6$254 Stars 4 Stars View Abstract
12-Jan-10Argus Research CorporationDavid ColemanVickers Weekly insider, 01/12/201062$50  View Abstract
7-Jan-10Zacks Investment Research Inc.N/ACHELSEA THERAP (CHTP) Zacks Company Snapshot1$10  View Abstract
6-Jan-10Zacks Investment Research Inc.N/ACHELSEA THERAP (CHTP) Zacks Company Snapshot1$10  View Abstract
Next 14
Brokerage Reports (Showing 1 to 4 of 4)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
19-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary14$50  View Abstract
19-Jan-10Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew Vaino PhDRaising Price Target After Chatting With Chelsea6$254 Stars 4 Stars View Abstract
4-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary13$50  View Abstract
4-Jan-10Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew Vaino PhDA 2010 Catalyst Calendar Of Roth Biotech Coverage8$25 4 Stars View Abstract
Independent Reports (Showing 1 to 10 of 20)
Release
Date [down]		 Contributor Author Title Pages Price More Info
6-Feb-10Standard & Poor's Quantitative ReportN/AChelsea Therapeutics Intl6$25View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: CHELSEA THERAPEU -- CHTP1$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ALSE , CVM , CHTP , CYCC , CUR -- DRUGS3$4View Abstract
25-Jan-10Argus Research CorporationDavid ColemanVickers Weekly Insider, 01/25/1029$50View Abstract
21-Jan-10Zacks Investment Research Inc.N/ACHELSEA THERAP (CHTP) Zacks Company Snapshot1$10View Abstract
12-Jan-10Argus Research CorporationDavid ColemanVickers Weekly insider, 01/12/201062$50View Abstract
7-Jan-10Zacks Investment Research Inc.N/ACHELSEA THERAP (CHTP) Zacks Company Snapshot1$10View Abstract
6-Jan-10Zacks Investment Research Inc.N/ACHELSEA THERAP (CHTP) Zacks Company Snapshot1$10View Abstract
6-Jan-10Global Markets DirectGlobal Markets DirectChelsea Therapeutics International, Ltd. Financial and Strategic Analysis Review17$300View Abstract
5-Jan-10Zacks Investment Research Inc.N/ACHELSEA THERAP (CHTP) Zacks Company Snapshot1$10View Abstract
Next 10

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.